Stability of erythropoietin repackaging in polypropylene syringes for clinical use

Introduction: Epoetin alfa (Eprex®) is a subcutaneous, injectable formulation of short half-life recombinant human erythropoietin (rHuEPO). To current knowledge there are no published studies regarding the stability of rHuEPO once repackaging occurs (r-EPO) for clinical trial purposes. Materials and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsili, Angela, Puorro, Giorgia, Pane, Chiara, de Rosa, Anna, Defazio, Giovanni, Casali, Carlo, Cittadini, Antonio, de Michele, Giuseppe, Florio, Brunello Ettore, Filla, Alessandro, Saccà, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355549/
https://www.ncbi.nlm.nih.gov/pubmed/28344481
http://dx.doi.org/10.1016/j.jsps.2016.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355549/
https://www.ncbi.nlm.nih.gov/pubmed/28344481
http://dx.doi.org/10.1016/j.jsps.2016.01.003

Ejemplares similares